Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patients.

Taubert H, Heidenreich C, Holzhausen HJ, Schulz A, Bache M, Kappler M, Eckert AW, Würl P, Melcher I, Hauptmann K, Hauptmann S, Schaser KD.

BMC Cancer. 2010 Feb 24;10:65. doi: 10.1186/1471-2407-10-65.

2.

Prognostic significance of bcl-2, c-myc, survivin and tumor grade in synovial sarcoma.

Demır D, Yaman B, Anacak Y, Keçecı B, Kandıloğlu G, Akalin T.

Turk Patoloji Derg. 2014;30(1):55-65. doi: 10.5146/tjpath.2013.01221.

3.

Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.

Kappler M, Kotzsch M, Bartel F, Füssel S, Lautenschläger C, Schmidt U, Würl P, Bache M, Schmidt H, Taubert H, Meye A.

Clin Cancer Res. 2003 Mar;9(3):1098-104.

4.

[Nuclear and cytoplasmic expressions of survivin in glioma and their prognostic value].

Pan Y, Hu WH, Xie D, Wu QL, Liu YH, Xiang J, Wu HX.

Zhonghua Yi Xue Za Zhi. 2007 Jan 30;87(5):325-9. Chinese.

PMID:
17456361
5.

Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.

West RB.

Adv Anat Pathol. 2010 Sep;17(5):366-73. doi: 10.1097/PAP.0b013e3181ec7428. Review.

PMID:
20733355
6.

Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.

Kohashi K, Oda Y, Yamamoto H, Tamiya S, Matono H, Iwamoto Y, Taguchi T, Tsuneyoshi M.

Mod Pathol. 2010 Jul;23(7):981-90. doi: 10.1038/modpathol.2010.71. Epub 2010 Mar 19.

7.

Nuclear or cytoplasmic expression of survivin: what is the significance?

Li F, Yang J, Ramnath N, Javle MM, Tan D.

Int J Cancer. 2005 Apr 20;114(4):509-12. Review.

8.

Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.

Reis H, Hager T, Wohlschlaeger J, Bauer S, Katenkamp K, Katenkamp D, Baba HA.

Hum Pathol. 2013 Oct;44(10):2266-74. doi: 10.1016/j.humpath.2013.04.018. Epub 2013 Jul 17.

PMID:
23871289
10.

Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.

Saito T, Arifin MT, Hama S, Kajiwara Y, Sugiyama K, Yamasaki F, Hidaka T, Arita K, Kurisu K.

J Neurooncol. 2007 Apr;82(2):193-8. Epub 2006 Dec 7.

PMID:
17151933
11.

Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.

Grabowski P, Griss S, Arnold CN, Hörsch D, Göke R, Arnold R, Heine B, Stein H, Zeitz M, Scherübl H.

Neuroendocrinology. 2005;81(1):1-9. Epub 2005 Apr 4.

PMID:
15809513
12.

Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival.

Martinez A, Bellosillo B, Bosch F, Ferrer A, Marcé S, Villamor N, Ott G, Montserrat E, Campo E, Colomer D.

Am J Pathol. 2004 Feb;164(2):501-10.

13.

TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.

Kosemehmetoglu K, Vrana JA, Folpe AL.

Mod Pathol. 2009 Jul;22(7):872-8. doi: 10.1038/modpathol.2009.47. Epub 2009 Apr 10.

14.

Prognostic relevance of survivin in pancreatic endocrine tumors.

Ekeblad S, Lejonklou MH, Stålberg P, Skogseid B.

World J Surg. 2012 Jun;36(6):1411-8. doi: 10.1007/s00268-011-1345-7.

15.

[Expression of TEIF protein in soft tissue tumors and its significance].

Gong YL, Li T, Guo H, Sun Y, Chi YK, Ling Y, Shen Q, Liu HJ, Hou L, Zhang B.

Zhonghua Bing Li Xue Za Zhi. 2006 Nov;35(11):651-5. Chinese.

PMID:
17374207
16.

Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.

Brennan DJ, Rexhepaj E, O'Brien SL, McSherry E, O'Connor DP, Fagan A, Culhane AC, Higgins DG, Jirstrom K, Millikan RC, Landberg G, Duffy MJ, Hewitt SM, Gallagher WM.

Clin Cancer Res. 2008 May 1;14(9):2681-9. doi: 10.1158/1078-0432.CCR-07-1760.

17.

Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.

Kawauchi S, Goto Y, Liu XP, Furuya T, Oga A, Oda Y, Tsuneyoshi M, Ihara K, Sasaki K.

Cancer. 2001 Mar 1;91(5):1005-12.

PMID:
11251953
18.

[Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].

Sun Y, Sun BC, Zhao XL, Wang J, Chen J, Li XQ, Feng YM, Fang ZW, Hao XS.

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):480-4. Chinese.

PMID:
17845763
19.

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer.

Vischioni B, van der Valk P, Span SW, Kruyt FA, Rodriguez JA, Giaccone G.

Ann Oncol. 2004 Nov;15(11):1654-60.

PMID:
15520067
20.

Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.

Kawauchi S, Fukuda T, Oda Y, Saito T, Oga A, Takeshita M, Yokoyama K, Chuman H, Iwamoto Y, Sasaki K, Tsuneyoshi M.

Mod Pathol. 2000 Jul;13(7):755-65.

Supplemental Content

Support Center